Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

No Comments

New opioid analgesic from Glaxo Wellcome

April 21, 1997

No Comments

U.K. approval for Edronax

April 21, 1997

No Comments

Imitrex Nasal Spray introduced in Canada

April 21, 1997

No Comments

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

No Comments

Synergistic benefit of citicoline and NMDA antagonist shown in animal models of stroke

April 18, 1997

No Comments

BASF describes new glutamate antagonists

April 18, 1997

No Comments

Naropin introduced in Germany

April 18, 1997

No Comments

Aricept launched in U.K.

April 18, 1997

No Comments

Update on Neurogen's schizophrenia program

April 18, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

MS&D designs potent and selective dopamine D4 antagonist

New opioid analgesic from Glaxo Wellcome

U.K. approval for Edronax

Imitrex Nasal Spray introduced in Canada

Warner-Lambert describes new dopamine D4 antagonists

Synergistic benefit of citicoline and NMDA antagonist shown in animal models of stroke

BASF describes new glutamate antagonists

Naropin introduced in Germany

Aricept launched in U.K.

Update on Neurogen's schizophrenia program

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Neurology/psychiatric RSS

Neurology/psychiatric
RSS